C
Christophe Mariat
Researcher at Jean Monnet University
Publications - 231
Citations - 7939
Christophe Mariat is an academic researcher from Jean Monnet University. The author has contributed to research in topics: Renal function & Transplantation. The author has an hindex of 43, co-authored 190 publications receiving 6245 citations. Previous affiliations of Christophe Mariat include Harvard University & Beth Israel Deaconess Medical Center.
Papers
More filters
Journal ArticleDOI
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Ch. Legendre,Christoph Licht,Petra Muus,Laurence Greenbaum,Sunil Babu,C. Bedrosian,C. Bingham,David J. Cohen,Y. Delmas,Kenneth W. Douglas,Frank Eitner,Thorsten Feldkamp,Denis Fouque,Richard R. Furman,Osama Gaber,Maria Herthelius,Maryvonne Hourmant,Diana Karpman,Yvon Lebranchu,Christophe Mariat,Jan Menne,Bruno Moulin,Jens Nürnberger,Masayo Ogawa,Giuseppe Remuzzi,T. Richard,Rebecca Sberro-Soussan,B. Severino,Neil S. Sheerin,Antonella Trivelli,L.B. Zimmerhackl,Timothy H.J. Goodship,Chantal Loirat +32 more
TL;DR: Eculizumab inhibited complement-mediated thrombotic microangiopathy and was associated with significant time-dependent improvement in renal function in patients with atypical hemolytic-uremic syndrome and was also associated with improvement in health-related quality of life.
Journal ArticleDOI
An estimated glomerular filtration rate equation for the full age spectrum
Hans Pottel,Liesbeth Hoste,Laurence Dubourg,Natalie Ebert,Elke Schaeffner,Bjørn Odvar Eriksen,Toralf Melsom,Edmund J. Lamb,Andrew D. Rule,Stephen T. Turner,Richard J. Glassock,Vandréa De Souza,Luciano Selistre,Christophe Mariat,Frank Martens,Pierre Delanaye +15 more
TL;DR: The new FAS equation has improved validity and continuity across the full age-spectrum and overcomes the problem of implausible eGFR changes in patients which would otherwise occur when switching between more age-specific equations.
Journal ArticleDOI
Predicting the Risk for Dialysis or Death in IgA Nephropathy
TL;DR: The absolute renal risk score, determined at diagnosis, associates with risk for dialysis or death in patients with primary IgA nephropathy.
Journal ArticleDOI
Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation.
Lionel Rostaing,Diego Cantarovich,Georges Mourad,Klemens Budde,Paolo Rigotti,Christophe Mariat,Raimund Margreiter,Luis Capdevilla,Phillippe Lang,P. Vialtel,Joaquin Ortuño-Mirete,Bernard Charpentier,Christophe Legendre,Jaime Sanchez-Plumed,Federico Oppenheimer,Michèle Kessler +15 more
TL;DR: Coricosteroid-free immunosuppression with a Dac/Tac/MMF regimen is as effective at preventing acute rejection after renal transplantation as a standard triple regimen of Tac/MMf/corticosteroids, and the safety benefits reported with Dac-Tac-MMF treatment may help improve the long-term outcome for renal-transplant patients.
Journal ArticleDOI
Autoantibodies Targeting Galactose-Deficient IgA1 Associate with Progression of IgA Nephropathy
F. Berthoux,F. Berthoux,Hitoshi Suzuki,Lise Thibaudin,Lise Thibaudin,Hiroyuki Yanagawa,Nicolas Maillard,Nicolas Maillard,Christophe Mariat,Christophe Mariat,Yasuhiko Tomino,Bruce A. Julian,Jan Novak +12 more
TL;DR: Serum levels of IgG and IgA autoantibodies strongly associate with the progression of IgAN nephropathy, and increasing levels correlated with worse clinical outcomes.